Tag Archives: clinical diagnostics

Rayno Life Sciences: First Half Stock Performance Part 2-ILMN, SQNM

Rayno Diagnostics and Tools-Sequencing Rules Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that are more revenue and earnings driven -Cardiovascular Systems(CSII) and Quidel (QDEL)- did not recover to former highs. Sequenom  (SQNM) is a leader in non-invasive pre-natal tests such […]

Comments Off Continue Reading →

Clinical Tools and Diagnostic Companies:Financial Metrics 2014 Q1Results

Clinical Diagnostic Stocks Were Hit By Bio-Bubble or Revenue Miss Potential upside in EXAS, NSTG and NEOG all are Rayno Dx and Tools picks. With “momentum trading” days over for now, revenue growth is the focus. Companies with disappointing Q1 revenues: Abaxis (ABAX), Alere (ALR), Response Genetics (RGDX) and Quidel (QDEL). Q2 recovery will be key. […]

Comments Off Continue Reading →

Rayno Dx and Tools 2014 YTD After Correction: ILMN, HOLX, RHHBY

April Sell-Off Hit Diagnostic Small and Mid Caps The bursting of the biotech bubble affected many small cap growth stocks. 2013 was a great year for our portfolio so some weakness was expected after the huge Q1 2014 moves. Most of our picks peaked in Jan/Feb time frame when many of our favorites were hit […]

Comments Off Continue Reading →

Rayno DX and Tools: Trading Pick of the Day Trinity Biotech (TRIB)

Trinity Biotech (TRIB $24.90), a Buy Around $25 Barrons published an article over the weekend recommending Trinity Biotech plc, an Irish diagnostic Company focused in point of care (POC) and clinical laboratory diagnostic tests. We agree with the article and will provide a follow-up review this week. Trinity Biotech tests are for infectious diseases, diabetes […]

Comments Off Continue Reading →

Rayno Life Science: Tools and Diagnostics Q1 2014 Performance

Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still had a good quarter with the following top winners: Illumina (ILMN) up 25.2%, Vermillion (VRML) up 25%, Exact Sciences (EXAS) up 21% […]

Comments Off Continue Reading →

Rayno Dx and Tools Stocks Up in January: CPHD, ILMN

Molecular Diagnostics and Sequencing Technologies  Are Big Winners in January 2014 But Recent Two Day Sell-Off Has Done Damage To Many Stocks Diagnostic stocks were a sea of red today after a huge January driven by growth expectations from new products and platform molecular technologies. As financial reporting is due for many of these stocks this […]

Comments Off Continue Reading →